The nanobodies were applied in a blocking buffer for 30 min, with three PBS washes between the nanobodies and the application of the secondary nanobody
References Abel ED, Gloyn AL, Evans-Molina C, et al
The foundational pharmacology paper described 5-Amino-1MQ as a potent, membrane-permeable inhibitor with strong selectivity for NNMT compared with the other methyltransferases tested in that research programme
Stroke is also the only neurologic condition with an FDA-accepted objective functional endpoint (Fugl-Meyer Assessment Score, including objective motor metrics), providing a validated, quantitative efficacy measure that helps de-risk approval
Baseline labs such as growth hormone and IGF-1 levels help create a treatment plan and allow your clinician to monitor your response
Items marked "" are certified